THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 152 filers reported holding THERAPEUTICSMD INC in Q2 2020. The put-call ratio across all filers is 1.82 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,352,000 | +6.9% | 6,189,834 | 0.0% | 0.03% | +23.8% |
| Q4 2021 | $2,200,000 | -52.1% | 6,189,834 | 0.0% | 0.02% | -55.3% |
| Q3 2021 | $4,589,000 | -37.7% | 6,189,834 | 0.0% | 0.05% | -38.2% |
| Q2 2021 | $7,366,000 | -11.2% | 6,189,834 | 0.0% | 0.08% | -6.2% |
| Q1 2021 | $8,294,000 | +10.7% | 6,189,834 | 0.0% | 0.08% | +8.0% |
| Q4 2020 | $7,490,000 | -23.4% | 6,189,834 | 0.0% | 0.08% | -31.8% |
| Q3 2020 | $9,780,000 | +26.4% | 6,189,834 | 0.0% | 0.11% | +22.2% |
| Q2 2020 | $7,737,000 | +17.9% | 6,189,834 | 0.0% | 0.09% | -2.2% |
| Q1 2020 | $6,561,000 | -15.0% | 6,189,834 | +94.0% | 0.09% | 0.0% |
| Q4 2019 | $7,719,000 | -33.3% | 3,189,834 | 0.0% | 0.09% | -37.4% |
| Q3 2019 | $11,579,000 | +39.6% | 3,189,834 | 0.0% | 0.15% | +42.7% |
| Q2 2019 | $8,294,000 | +72.1% | 3,189,834 | +222.3% | 0.10% | +68.9% |
| Q1 2019 | $4,820,000 | +80.3% | 989,834 | +41.0% | 0.06% | +56.4% |
| Q4 2018 | $2,674,000 | – | 701,875 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 1492 Capital Management LLC | 387,529 | $2,341,000 | 1.83% |
| SANDERS MORRIS HARRIS LLC | 521,500 | $3,150,000 | 1.33% |
| Newtyn Management, LLC | 1,250,000 | $7,550,000 | 1.15% |
| ARDSLEY ADVISORY PARTNERS LP | 1,050,000 | $6,342,000 | 0.77% |
| NEXTHERA CAPITAL LP | 528,351 | $3,191,000 | 0.59% |
| MORGENS WATERFALL VINTIADIS & CO INC | 112,000 | $676,000 | 0.53% |
| Capital Impact Advisors, LLC | 200,707 | $1,212,000 | 0.52% |
| SPHERA FUNDS MANAGEMENT LTD. | 479,980 | $2,899,000 | 0.34% |
| Rock Springs Capital Management LP | 1,175,000 | $7,097,000 | 0.32% |
| QCM Cayman, Ltd. | 11,493 | $69,000 | 0.29% |